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Abstract
Background: The CASTLE (Candida and Staphylococcus Transmission: Longitudinal Evaluation) study will
investigate the micro-organisms involved in the development of mastitis and “breast thrush” among breastfeeding
women. To date, the organism(s) associated with the development of breast thrush have not been identified. The
CASTLE study will also investigate the impact of physical health problems and breastfeeding problems on maternal
psychological health in the early postpartum period.
Methods/Design: The CASTLE study is a longitudinal descriptive study designed to investigate the role of
Staphylococcus spp (species) and Candida spp in breast pain and infection among lactating women, and to
describe the transmission dynamics of S. aureus and Candida spp between mother and infant. The relationship
between breastfeeding and postpartum health problems as well as maternal psychological well-being is also
being investigated. A prospective cohort of four hundred nulliparous women who are at least thirty six weeks
gestation pregnant are being recruited from two hospitals in Melbourne, Australia (November 2009 to June
2011). At recruitment, nasal, nipple (both breasts) and vaginal swabs are taken and participants complete a
questionnaire asking about previous known staphylococcal and candidal infections. Following the birth,
participants are followed-up six times: in hospital and then at home weekly until four weeks postpartum.
Participants complete a questionnaire at each time points to collect information about breastfeeding problems
and postpartum health problems. Nasal and nipple swabs and breast milk samples are collected from the
mother. Oral and nasal swabs are collected from the baby. A telephone interview is conducted at eight weeks
postpartum to collect information about postpartum health problems and breastfeeding problems, such as
mastitis and nipple and breast pain.
Discussion: This study is the first longitudinal study of the role of both staphylococcal and candidal colonisation in
breast infections and will help to resolve the current controversy about which is the primary organism in the
condition known as breast thrush. This study will also document transmission dynamics of S. aureus and Candida
spp between mother and infant. In addition, CASTLE will investigate the impact of common maternal physical
health symptoms and the effect of breastfeeding problems on maternal psychological well-being.
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Background
The World Health Organization and Australian authori-
ties recommend that babies are exclusively breastfed for
the first six months of life [1,2]. During this time, and
especially in the early weeks, breastfeeding women can
experience a range of breastfeeding problems, in particular
breast and nipple pain, or breast infections such as mastitis
or “breast thrush”.
Mastitis is an acute, debilitating infection that occurs in
15 to 20% of Australian breastfeeding women who experi-
ence a red, painful breast with fever [3,4]. Seventy five per-
cent of mastitis episodes occur in the first seven weeks
following birth [4]. It is a painful, distressing condition
which may require hospitalisation or lead to development
of a breast abscess [5]. Traditionally, S. aureus has been
considered the most common aetiological agent of mastitis
and is commonly isolated in infective mastitis and from
breast abscesses [6]. However, recent studies have sug-
gested that other micro-organisms such as coagulase nega-
tive staphylococci (CNS) may also play an important role
in infectious mastitis [7,8]. CNS such as Staphylococcus
epidermidis are normal inhabitants of the skin in healthy
hosts and are considered commensal bacterial skin flora.
The suggestion that CNS such as S. epidermidis may be
involved in infective mastitis highlights that, although
S. aureus is certainly one cause of mastitis, commensal
skin flora which have previously been thought of as non-
pathogenic, may also be responsible for this illness in a
proportion of breastfeeding women [7].
Breastfeeding women may also experience burning
nipple/breast pain known as breast thrush (not asso-
ciated with breast redness or fever) which occurs in
about 10% of breastfeeding women [9,10]. While the
aetiology of mastitis has been investigated, the organism
(s) associated with the development of breast thrush
have not been identified. Some researchers and clini-
cians believe that the underlying pathogenesis in lactat-
ing women with burning nipple and breast pain is
infection with C. albicans [10-12]. However, it has
proved difficult to identify this organism from breast
milk [13], and others attribute the pain to infection
with S. aureus and treat women with long-term anti-
staphylococcal antibiotics [14]. Another possibility is
that this syndrome could be caused by multiple organ-
isms. Co-infection with S. aureus and C. albicans or
other Candida spp in the lactating nipple and breast
may be leading to inflammation and pain. These organ-
isms co-exist in infectious conditions in other moist
parts of the body, such as angular cheilitis (in the cor-
ners of the mouth) [15,16] and paronychia (infection
around the finger nail) [17]. This is currently a hotly
debated issue and the pathogenesis of breast thrush is
unclear [18,19].
In addition to breast symptoms and infection, maternal
physical symptoms in the postpartum period are common.
The Victorian Survey of Recent Mothers, a state-wide
postal survey of a representative cohort of 1336 women,
found that at six months postpartum, 94% of the sample
reported one or more health problems [20]. The most
common health problems reported were fatigue (69%),
backache (43%), sexual problems (26%), haemorrhoids
(25%) and perineal pain (21%) [20]. The impact of these
postpartum health problems and breastfeeding problems
on women’s overall functioning and on their psychological
well-being has not been widely investigated.
The CASTLE (Candida and Staphylococcus Transmis-
sion: Longitudinal Evaluation) study is a longitudinal
study which aims to investigate the organisms involved
in both breast thrush and mastitis. At recruitment, base-
line samples will be collected from mothers’ nipples,
nose and vagina. Postpartum, we will collect follow-up
samples from infants’ mouths and nose, mothers’ nip-
ples and nose, and milk samples from each breast. We
will also collect data on clinical outcomes, which will
enable us to determine if S. aureus and/or Candida spp
are involved in breast thrush. Furthermore, breast milk
samples and nipple swabs will address whether coagu-
lase negative staphylococci play a role in infective masti-
tis among participants. Data obtained will also allow us
to describe the colonisation of infants with S. aureus
and Candida spp, and investigate their transmission
dynamics between mother and infant.
In addition to the microbiological aspects of the study,
CASTLE will investigate the impact of breastfeeding
problems and postpartum health problems on maternal
psychological well-being. The repeated data collection
intervals in the CASTLE study provide a unique oppor-
tunity to prospectively investigate the role breastfeeding
difficulties and physical health complaints play in deter-
mining maternal mood and psychological well-being in
the early postpartum period.
Methods/Design
Aims
Specific aims of the study are:
1. To determine whether S. aureus and/or Candida
spp are involved in burning nipple/breast pain in lactat-
ing women - the condition known as breast thrush -
using a longitudinal study for the first time;
2. To increase understanding of transmission
dynamics and infant colonisation of these organisms by
describing the timing of oral and nasal colonisation with
S. aureus and Candida spp in breastfed infants and
determining the role of infant colonisation with these
organisms in relation to the timing of maternal mastitis
and breast thrush;
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3. To investigate comprehensively whether staphylo-
cocci other than S. aureus (coagulase-negative staphylo-
cocci) play a role in infective mastitis;
4. To ascertain the impact of common maternal physi-
cal health symptoms and breastfeeding problems on
maternal psychological well-being at four and eight
weeks postpartum, adjusting for known determinants of
poorer postnatal mood.
Study hypotheses
Pre-specified study hypotheses for the microbiological
components of CASTLE are:
1. Women reporting nipple and breast candidiasis are
more likely to have Candida spp isolated from their
swabs and breast milk samples and/or from swabs taken
from their infants;
2. Women reporting nipple and breast candidiasis are
more likely to have S. aureus isolated from isolated
from their swabs and breast milk samples and/or from
swabs taken from their infants;
3. Participants experiencing mastitis are more likely to
have S. aureus isolated from their breast milk compared
to women not reporting this condition;
4. Infants of women reporting mastitis are more likely
to have S. aureus isolated from their oral and/or nasal
swabs compared to healthy controls;
5. Women who report an over-supply of breast milk
are more likely to develop mastitis compared to women
who report an adequate supply or under-supply of
breast milk;
6. Women who report the use of hydrogel dressings in
the postpartum period are more likely to develop masti-
tis compared to women who do not use these dressings;
7. Women who report a greater time between feeds
are more likely to develop mastitis;
8. Women reporting nipple damage on the tip of their
nipple are more likely to develop mastitis than women
reporting no damage, or reporting damage elsewhere on
the nipple;
9. Women administered antibiotics in labour or post-
partum are more likely to develop nipple and breast
candidiasis than women not treated with antibiotics dur-
ing these periods.
Pre-specified study hypotheses for the psychological
components of CASTLE are:
1. Women reporting two or more physical symptoms
on at least two occasions between one and four weeks
postpartum will have measurably worse psychological
outcomes on two standardised assessments of maternal
mood at four and eight weeks postpartum after adjust-
ing for known determinants of poor maternal mood
(lower antenatal mood, insufficient partner support,
prior history of mood disturbance, personality style, and
infant factors);
2. Women reporting breastfeeding problems (includ-
ing mastitis, nipple/breast pain, low milk supply) will
have measurably worse psychological outcomes on two
standardised assessments of maternal mood at four and
eight weeks postpartum after adjusting for known deter-
minants of poor maternal mood (lower antenatal mood,
insufficient partner support, prior history of mood dis-
turbance, personality style, and infant factors);
3. Women reporting nipple or breast pain (> 5/10 on
the pain scale) on two or more occasions, will have
more psychological symptoms at the time of the nipple/
breast pain than those experiencing less pain (≤ 5/10),
or those reporting pain at only one study interval;
4. Women with mastitis will have more psychological
symptoms at the data collection point at the time of the
episode/immediately following the episode than those
reporting no mastitis;
5. Women who have had breastfeeding problems
resolved will have better mood scores than those unre-
solved at eight weeks;
6. Women continuing to breastfeed at eight weeks will
have better mood scores than women not breastfeeding.
Sample
Four hundred women and their newborn infants form
the study group. Women are recruited in The Royal
Women’s Hospital (RWH), Melbourne and Frances
Perry House (FPH), a private hospital located on the
same site; approximately two hundred women from
each site. Four hundred women will be recruited to
allow for 20% loss as some may not breastfeed or give
up prematurely/withdraw from study/lost to follow-up.
Eligibility criteria for the study group are: between 18
- 50 years of age; nulliparity; ≥ 36 weeks pregnant at
recruitment; singleton pregnancy; breastfeeding inten-
tion for at least eight weeks postpartum; sufficient profi-
ciency in English to complete written questionnaires
and a telephone interview; residing ≤ 10 km from Mel-
bourne Central Business District (CBD). Criteria for
exclusion are: medical conditions which do not allow
breastfeeding; breast reduction surgery; dermatitis on
nipple during pregnancy; under care of the Women’s
Hospital Alcohol and Drug Service; under care of
Mental Health Service or Social Worker.
Sample size
Sample size estimations were conducted using Epi-Info
Version 6. Table 1 shows power calculations for the
study with alpha of 0.05 and beta of 0.20. Sample size
calculations assume a ratio of 1:1 (unexposed: exposed)
for comparison of infants colonised with S. aureus
(assuming that about 50% of young infants are colonised
with S. aureus [21]). To detect a clinically significant dif-
ference in the outcome of maternal breast thrush from
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5% in the unexposed group to 15% in the group exposed
to infant S. aureus colonisation, a sample of three hun-
dred and eighteen women are needed. If we based the
calculation on infants colonised with Candida spp (four
not colonised to one colonised), two hundred and
seventy women are required in order to have enough
power to identify a clinically significant increase, a two-
fold relative risk in breast thrush in mothers of infants
with oral Candida spp (20% to 40%). Therefore, a sam-
ple size of four hundred was considered sufficient to
detect clinically important differences in breast thrush
and mastitis associated with infant colonisation with S.
aureus and Candida spp, (alpha = 0.05, beta = 0.20),
allowing for 20% loss to follow-up or withdrawal from
the study. This will allow us to examine other outcomes
of interest, including determinants of maternal mastitis.
Recruitment procedures
Participants are recruited antenatally by one of two meth-
ods. Research assistants speak at antenatal breastfeeding
classes run by both RWH and FPH to introduce the study.
Interested women attending these classes provide a con-
tact telephone number and are contacted when they are
thirty six weeks pregnant and recruited to the study after
giving informed consent. Alternatively, participants are
recruited at routine antenatal visits at either the public
antenatal outpatient clinics (RWH) or at private obstetric
practices (FPH), after at least thirty six weeks of preg-
nancy. Potential participants are approached in the clinic
waiting areas, and their English competency, parity and
intention to breastfeed ascertained.
If interested in the study, verbal and written informa-
tion about the study is offered. Eligible women are given
an invitation package which contains: (i) a leaflet explain-
ing the purpose of the study and inviting women to take
part; (ii) a plain language statement with further detail
about the study and study consent forms; (iii) a sheet for
recording contact details and, (iv) the first study ques-
tionnaire (Q1). Signed consent and participant contact
details are obtained. At recruitment, baseline samples are
collected from mothers’ nipples, nose and vagina.
Follow-up procedures
All contact with study participants after recruitment is
managed by the CASTLE research team based at
Mother & Child Health Research (MCHR). Researchers
visit the postnatal wards each day to identify whether
any participant has given birth in the previous twenty
four hours. Participants who are in the hospital follow-
ing birth are visited by the researcher in the first day(s)
after birth, and are invited to complete a written ques-
tionnaire. Samples are collected from infants’ mouths
and nose and mothers’ nipples and nose. A sample of
colostrum is collected from each breast if possible.
At the end of weeks 1, 2, 3 and 4 postpartum,
researchers visit participants at home to collect the
same samples for the microbiological aspects of the
CASTLE study. During these home visits, participants
again complete written questionnaires. If participants
cease breastfeeding during this time, no further home
visits are conducted. At week 8, regardless of breastfeed-
ing status, participants are contacted by telephone, to
complete a final questionnaire.
Ethical issues
Each participant gives informed consent to participate in
the study and for information to be obtained from their
hospital medical records, with the condition that they are
free to withdraw at any time. Participants can consent to
the microbiological aspects and the psychological aspects
of the study separately.
Upon withdrawal, participants can request that data
arising from their participation are not used in the
research project provided that this right is exercised
within four weeks of the completion of their participa-
tion in the project.
Any information obtained in connection with this pro-
ject, and which could identify participants will remain con-
fidential and be stored in a secure location at MCHR, La
Trobe University. Only the chief investigator, study co-
ordinator and research assistants see personal information.
Participants are assigned a unique study number and
all data associated with the study are identified using
this number. Data will be stored in a securely locked
cabinet at MCHR for five years after the date of publica-
tion and then destroyed in a secure manner.
Ethics approval for the study has been granted by:
• La Trobe University Human Ethics Committee
(06-078);
Table 1 Sample size estimations for the CASTLE study
Exposure ratio
(unexposed: exposed)
Outcome of interest Difference Sample size estimate
Infant no nasal S. aureus /infant nasal S. aureus (1:1) Mother breast thrush 5% versus 15% 318
Infant no nasal S. aureus /infant nasal S. aureus (1:1) Mother mastitis 12% versus 25% 308
Infant no oral Candida/infant oral Candida (4:1) Mother breast thrush 20% versus 50% 130
Infant no oral Candida/infant oral Candida (4:1) Mother breast thrush 20% versus 40% 270
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• RWH Human Research Ethics Committee (06/41
for the microbiological aspects of the study and 09/
48 for the psychological components of the study);
• Human Research Ethics Committee of the Univer-
sity of Melbourne (1033949);
• Medical Advisory Committee at FPH.
Data collection
1. Questionnaires
At recruitment, women complete a questionnaire to col-
lect information about maternal age, gestational age,
intended length of breastfeeding duration, history of
thrush and staphylococcal infections, history of allergies
(asthma, hay fever, eczema and dermatitis) [22], antibiotic
use, highest level of educational attainment, and marital
status. Participants recruited to the psychological compo-
nent of CASTLE also complete a written self-report ques-
tionnaire comprised of the Profile of Mood States (PoMS)
[23], the Depression, Anxiety and Stress Scale (DASS) [24]
and the Vulnerable Personality Scale (VPS) [25]. Prior his-
tory of psychological problems is also ascertained.
Follow-up questionnaires at weeks 1, 2, 3, 4 and 8 post-
partum collect information about nipple/breast pain, milk
supply, breast candidiasis, mastitis, nipple damage, other
infections and antibiotic use. Information on the use of
breast pumps and milk expression is also obtained [26].
The birthing method, induction of labour, administration
of antibiotics during labour and perineal trauma are also
collected in the first postpartum questionnaire.
Women are asked if they are fully breastfeeding (i.e. no
infant formula), if the baby is receiving expressed breast
milk, if the baby is receiving formula and whether the
majority of feeds are breast milk or formula. There is no
standard way of diagnosing mastitis. Therefore, we ask
about a range of breast symptoms and associated fever or
flu-like symptoms as has been used previously [3,27].
The definition of mastitis is the development of at least
two breast symptoms (pain, redness, lump) and at least
one systemic symptom (fever or flu-like symptoms)
[3,27]. Francis-Morrill and colleagues [28] found that
nipple pain, associated with a shiny or flaky appearance
of the nipple and breast pain had a high positive predic-
tive value for nipple candidiasis. In this study we are ask-
ing about burning nipple pain, stabbing breast pain and
asking participants if they have been given a diagnosis of
nipple/breast candidiasis by any of their clinicians. Data
on treatments used are also collected. Researchers are
documenting nipple appearance and any nipple damage,
as described in previous studies [29,30] and breasts are
assessed for evidence of spreading infection. An algo-
rithm will be designed to enable a likely diagnosis on nip-
ple and breast candidiasis which incorporates women’s
reported symptoms, clinician’s diagnosis of nipple or
breast thrush and clinical appearance.
At weeks 1, 2, and 3 weeks postpartum, participants
completing the psychological components also complete
a short questionnaire on physical health symptoms and
the global self-rated assessment of physical health from
the SF-36 [31]. Participants also complete two visual
analogue scales (VAS) to assess “depression” and “emo-
tional lability”, developed by Kendell et al. [32]. At week
4 and 8, participants complete the PoMS and DASS
[23,24] in addition to the above (Table 2).
Infant behaviour and infant health are assessed using a
six-item scale rating infant sleeping, feeding and settling
and maternal experiences in caring for their infant.
These items have been adapted from those used by
investigator colleagues in a community cohort study of
nine hundred postpartum women [33]. Respondents are
asked to indicate any health problems or illnesses that
the infant has experienced, and when these episodes
occurred. Support from their intimate partner is also
assessed. Two items will assess support from partner
since the birth, including the adequacy of practical sup-
port they have received from their partner since the
birth, and whether or not they can confide in their
partner.
2. Microbiology
Samples are collected at each visit with participants
(Table 3) and are labelled with the date of collection, par-
ticipants’ date of birth and an identification number
unique to each participant. Mothers provide nasal, nipple
(both nipples) and vaginal swabs and breast milk samples
(both breasts). Two nipple swabs are obtained from each
nipple: a standard charcoal swab for microbiological ana-
lysis (Copan Diagnostics Inc.) and a flocked swab for
molecular analysis (Copan Diagnostics Inc.). Nasal and
oral swabs are obtained from infants. Baseline nasal, nip-
ple and vaginal swabs are obtained at recruitment. Fol-
low-up nasal, nipple and milk samples are taken from
women; follow-up nasal and oral swabs are obtained
from infants. A vaginal swab is obtained when women
present prior to birth if possible.
Nasal swabs are used for culture of S. aureus. Nipple
(charcoal), oral and vaginal swabs are used for culture of
S. aureus and Candida spp. Breast milk samples are used
for culture of S. aureus, CNS and Candida spp and nip-
ple swabs (flocked) are used for molecular identification
of Candida spp. The identity of tentative S. aureus iso-
lated from all samples is subsequently confirmed using
molecular methods which also analyse isolates for methi-
cillin resistance. CNS isolated from breast milk samples
are being stored to identify individual species and strains
by molecular techniques. Further specimens are obtained
from participants where appropriate (e.g. swab of a
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caesarean wound infection) and used for culture of
S. aureus and Candida spp.
In addition, all women are given a 70 ml sterile con-
tainer (Sarstedt Australia Pty. Ltd.) to be used to collect
a sample of milk should they develop mastitis during
the first eight weeks postpartum. They are asked to
express some milk (1 - 2 ml) from the affected breast
into the jar and contact one of the research assistants to
organise collection of the sample. This milk sample is
analysed as previously described.
With the exception of the vaginal swab, samples are
collected by the research assistant unless a participant
specifies a wish to collect the samples. Hands are sani-
tised and clean disposable gloves worn when collecting
samples. Hands are re-sanitised and a fresh pair of gloves
is worn for the collection of each subsequent sample.
Nasal and nipple swabs are moistened in sterile saline
(Thermo Fisher Scientific, Australia Pty. Ltd.) prior to
sample collection. Nasal swabs are rotated four times
around the inside of the right nasal vestibule and then
placed in Amies charcoal transport media for analysis.
Both the standard and flocked nipple swabs are rolled
over the nipple and areola together using a ten-point
swabbing technique [34] paying particular attention to
any cracks/fissures which may be present. Vaginal swabs
are taken from approximately 1 cm inside the vagina.
Oral swabs are taken from the dorsum of the tongue. All
standard swabs are placed in Amies charcoal transport
media prior to analysis.
After nipple swabs have been collected, the nipple/are-
ola region is washed twice using sterile water wipes
(Briemar Nominees Pty. Ltd.). The research assistant
then expresses and discards the first drops of breast
milk (approx 500 μl) before collecting mid-stream milk
(1 - 2 ml) into a sterile container. All samples are trans-
ported in an insulated container at 4°C to the Bacteriol-
ogy Laboratory at the Royal Children’s Hospital within
1 - 2 hr of collection. Samples remain refrigerated until
analysed.
S. aureus growth is indentified using Vogel-Johnson
(VJ) agar [35]. This bacterium possesses the ability to
reduce tellurite to metallic tellurium, which results in
growth as black colonies. In addition, S. aureus is able to
ferment mannitol, resulting in a distinct yellow halo
Table 2 Summary of psychological component of the CASTLE study
Study
interval
Breast symptoms
(collected in CASTLE
study)
Physical
symptoms
SF-36*
self-rated physical
health
DASS-
21**
PoMS† Visual analogue scale, maternal
mood#
Recruitment • •
Hospital •
Week 1 • • • •
Week 2 • • • •
Week 3 • • • •
Week 4 • • • • • •
Week 8 • • • • •
*SF-36 self-rated global physical health item [31]
**Depression, Anxiety and Stress Scales (DASS-21) [24]
†Profile of Mood States (PoMS) [23]
#"Depression” and “Lability” items [32]
Table 3 Schedule of specimen collection for the CASTLE study (400 women)
RECRUITMENT LABOUR HOSPITAL WK 1 WK 2 WK 3 WK 4
Mother Nasal 1 1 1 1 1 1
Vaginal 1 1
Left nipple 2* 2* 2* 2* 2* 2*
Right nipple 2* 2* 2* 2* 2* 2*
Left breast milk 1 1 1 1 1
Right breast milk 1 1 1 1 1
Baby Nasal 1 1 1 1 1
Oral 1 1 1 1 1
TOTAL 6 1 9 9 9 9 9
* 2 swabs taken, one for culture analysis and one for molecular analysis
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around the black colony. During the initial 24 hr of incu-
bation contaminating organisms are almost completely
inhibited by tellurite, lithium chloride and the high gly-
cine concentration of the medium. All tentative S. aureus
are then sub-cultured onto Mannitol Salt (MSA) agar
(Thermo Fisher Scientific, Australia Pty. Ltd.) and pure
cultures stored in glycerol broths at -80°C.
MacConkey (MAC) agar (Thermo Fisher Scientific, Aus-
tralia Pty. Ltd.) is used to identify the presence of CNS.
Samples are plated onto MAC plates and morphologically
distinct isolates present are streaked onto MSA and incu-
bated for 24 hr. Due to the high salt concentration of this
medium, growth of most bacterial species except staphylo-
cocci and micrococci are inhibited. Colonies that are able
to ferment mannitol produce a distinct yellow colour
change in the media and are tentative S. aureus isolates.
S. aureus and CNS specimens are stored in glycerol broths
at -80°C for further molecular typing.
Candida CHROMagar is used to identify candida to
the species level of C. albicans, C. glabrata, C. krusei
and C. kefyr [36]. All fungal isolates (including those
other than the four previously mentioned species) are
stored in glycerol broths at -80°C.
3. Molecular analysis
Like many fungal genera, it is difficult to sensitively
detect Candida spp by conventional culture techniques.
This is especially true for samples such as swabs and
non-blood fluids, including breast milk [37-40]. To
increase sensitivity for the detection of Candida spp
from the nipple, a flocked swab is resuspended in 1×
Phosphate Buffered Saline (PBS) and DNA extracted
from this is subsequently used in a polymerase chain
reaction (PCR) which has been used previously to suc-
cessfully identify Candida spp [41,42].
Collected nipple swabs are analysed by quantitative,
real-time PCR. Nucleic acid is extracted from samples
using the Siemens Versant kPCR automated extraction
platform according to the manufacturer’s recommenda-
tions (Siemens Ltd.). A 10 μL aliquot of the resulting
DNA from two samples (left and right nipples) of each
woman is screened using Taqman probes specific for
C. albicans, C. krusei and C glabrata. A broad-range,
Candida spp probe is also included in the multiplex
assay. These probes target the RNase P RNA gene RPR1
[43], and are highly specific for their target sequences.
Confirmation of tentative S. aureus isolates and screen-
ing for methicillin resistance is carried out using multi-
plex PCR targeting the nuc gene of S. aureus and the
mecA gene of methicillin-resistant S. aureus (MRSA)
[44]. We plan to carry out pulsed-field gel electrophoresis
(PFGE) on selected isolates of S. aureus. This will be car-
ried out at the Gram-Positive Bacteria Typing and
Research Unit, Perth, and will allow comparison with
globally relevant community and clinical strains. The
PFGE profiles from S. aureus identified from mothers
(nasal, nipples, milk and vagina) will be compared to iso-
lates cultured from her infant’s mouth to ascertain
whether the same strain of the organism is present and
to determine transmission dynamics.
Species level identification of tentative CNS isolates is
determined by PCR targeting the Staphylococcus spp tuf
gene, which encodes for the prokaryotic elongation factor
TU [45]. Following CNS isolate confirmation, isolates are
stored for subsequent molecular typing. We plan to gen-
otype CNS isolates using random amplified polymorphic
DNA (RAPD) analysis [46]. The profiles of isolates from
an equal number of milk samples of women with mastitis
and without mastitis will be compared to see if there is a
correlation between particular strains and breast
infection.
Data analysis plan
The study co-ordinator monitors specimen collection
and ensures results are complete. Data from the ques-
tionnaires is entered into EpiData by an experienced
research assistant, and transferred to Stata for analysis.
The laboratory presents the microbiological results in an
Excel spreadsheet with is also imported into Stata for
analysis.
Descriptive analysis includes maternal demographic
characteristics, details about the birth, about breastfeed-
ing duration, nipple pain, breastfeeding difficulties, mas-
titis and maternal physical symptoms. Maternal and
infant characteristics and transmission dynamics are
described.
The relationship between infant colonisation with
S. aureus and infant colonisation with Candida spp and
maternal breast thrush will be tested by chi-square (or
Fisher’s exact if more appropriate). We will model the
timing of incidence of maternal mastitis using survival
analysis, with maternal and infant S. aureus carriage as
time-dependent co-variates, together with appropriate
variables (e.g. maternal age, method of birth, nipple
damage). We will model the presence of Candida spp in
vaginal/infant oral or nipple/milk samples and a diagnosis
of nipple/breast candidiasis.
For the psychological components of the study, the pri-
mary outcomes are the two standardised assessments of
maternal psychological symptoms - the PoMS and the
DASS [23,24]. Multivariate analyses (linear regression)
will be used to ascertain how much of the variation in
maternal psychological symptoms can be accounted for
by the presence of physical problems and breastfeeding
difficulties on the primary outcomes of maternal well-
being (DASS, PoMS) at four and eight weeks postpartum.
Known risk factors for worse maternal mood will be
adjusted for including unsettled infant behaviour, insuffi-
cient partner support, vulnerable personality traits and
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previous history of mood disturbance. Pregnancy mood
will also be adjusted for. Cross-sectional comparisons of
maternal mood will be conducted for women experien-
cing nipple/breast pain and/or mastitis and those without
nipple/breast symptoms.
Discussion
Changes to the protocol after the commencement of
recruitment in November 2009
Initial Ethics approval for the study had been granted by
the La Trobe University Human Research Ethics Com-
mittee and the RWH Human Research Ethics Commit-
tee for the microbiological aspects of the study, and
recruitment began in November 2009. Ethics approval
for the maternal physical and mental wellbeing compo-
nent of CASTLE was obtained on 2 June 2010. Women
were then invited to take part in the full study, but
could consent to the microbiological aspect of CASTLE
independently of the psychological component of the
study. We had recruited ninety eight women to CAS-
TLE before the introduction of the psychological aspects
of the study (Table 4).
Our original aim had been to recruit twenty two
women each month over an eighteen month period.
However, we were not achieving this and therefore
implemented several strategies in August 2010 aiming to
increase our recruitment figures to twenty eight women
per month (Table 4). The strategies included (i) increas-
ing the presence of research assistants at Pregnancy
Clinics at RWH; (ii) employment of additional research
staff to carry out postnatal visits and an additional scien-
tist to increase efficiency of microbiological analysis;
(iii) increasing the recruitment zone from ≤ 10 km to
≤ 16 km from Melbourne CBD.
Strengths and limitations of the study
The CASTLE study is a prospective longitudinal study
which will collect data and microbiological samples
from participants over time from approximately thirty
six weeks of pregnancy gestation until eight weeks post-
partum. This enables us to study transmission dynamics
of S. aureus and Candida spp, as well as investigate the
natural history of mastitis and breast thrush. A study of
this detail investigating the role of S. aureus, Candida
spp and CNS in the pathogenesis of breast pain and
infection in lactating women has not been conducted
previously. We need to understand these causal path-
ways before we can develop interventions to reduce
these infections in new mothers. Previous breastfeeding
studies have been cross-sectional; microbiological stu-
dies, while longitudinal, have not collected clinical data.
Furthermore, the repeated data collection intervals in
the CASTLE study provide a unique opportunity to pro-
spectively investigate the role breastfeeding difficulties
and physical health complaints play in determining
maternal mood and psychological well-being in the early
postpartum period.
One limitation of the CASTLE study is that partici-
pants are not representative of Australian women. Only
nulliparous women able to read and write in English,
who have reached thirty six weeks of pregnancy, plan-
ning to breastfeed for at least eight weeks after birth
and who live ≤ 16 km from the Melbourne CBD are eli-
gible to participate in the study. The rationale for
restricting eligibility to women who have reached thirty
six weeks gestation was to limit the number of preterm
births in the study as these infants may suffer health
complications and are less likely to breastfeed success-
fully. The reasoning behind restricting participation to
Table 4 Implementation and timeline for the CASTLE study
Date Activity
May 2009 Study co-ordinator appointed to oversee all aspects of CASTLE
Sept 2009 Approval granted from Medical Advisory committee at Frances Perry House (7 September 2009). Approval already granted by
La Trobe University (2 November 2008) and the Royal Women’s Hospital (20 February 2007).
Tracking database set-up.
Questionnaires, protocols and procedures finalised.
Oct 2009 2 part-time (0.5) research assistants appointed
Nov 2009 - June
2010
Research scientist commences.
Recruitment of participants to the microbiological aspects of the study and follow up for 8 weeks.
June 2010 - May
2011
Approval for psychological component of CASTLE granted by the Royal Women’s Hospital (2 June 2010).
Recruitment of participants to the microbiological and psychological aspects of the study and follow up for 8 weeks.
Feb 2010 - Sept
2011
Data entry and cleaning
Sept 2011 - March
2012
Data analysis
Sept 2011 - Sept
2012
Summary of results to participants
Write up papers for publication
Presentation at conferences
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nulliparous women was to more accurately follow the
transmission dynamics of S. aureus, CNS and Candida
spp from mother to baby without previous breastfeeding
history influencing maternal colonisation. Because of the
number of home visits to be completed by research
assistants involved in the study, we originally decided on
a recruitment limit of ≤ 10 km from the Melbourne
CBD. However, to increase recruitment figures, we
increased this zone to ≤ 16 km from the CBD in August
2010.
In addition, since approximately one third of Australian
women have private health insurance, this study has an
over-representation of women with private insurance.
These women may have an intention to breastfeed for
longer and tend to be more willing to participate in an
interview study. However, as the main aim is to describe
the pathogenesis of nipple/breast candidiasis, it was
important to recruit women with a high expectation of
breastfeeding for at least eight weeks as well as be willing
to complete participation.
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